Other articles:
|
Testing pre-transplant cytomegalovirus (CMV) status of donors and recipients to
As explained to me early on, a transplant is the process by which an . A. CMV
CMV status of heart transplant recipients and their respective donors does not
CYTOMEGALOVIRUS INFECTION STATUS PREDICTS. PROGRESSION OF
therapies taken to prevent organ rejection.(5-8). • The risk of CMV infection and
CMV status of the donor and the recipient influence the outcome of allogeneic
. was analyzed based on the CMV serological status before transplantation.
Aug 1, 2007 . CMV status of the donor and the recipient influence the outcome of allogeneic
Jan 13, 2011 . CMV is an immunomodulator and CMVD exacerbates the net state of
Oct 1, 1998 . In this newsletter, we would like to provide you with an update on the influence of
Feb 15, 1997 . Results: 1-year mortality rates for the four strata of donor and recipient CMV
Transplant recipients are particularly at risk of developing CMV infection because
Outcomes for Haemopoietic Stem Cell Transplantation (HCST) are improving .
Aug 27, 2010 . A brief presentation of CMV in Kidney Transplantation. . should be given to HLA-
Cytomegalovirus in transplantation - challenging the status quo. Fishman JA,
samples drawn to determine if they have the virus. If I test positive for CMV, will I
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status,
and Long-term Outcomes. Race, ethnicity. Age, Gender. CMV Status. Age at
insignificant (39.62±11.96 for the CMV positive patients and 38.71±12.16 for the
Evaluation of the CMV-CUBE Assay for Detection of. Cytomegalovirus Serologic
Conclusions: In the current era, survival after lung transplantation is statistically
Feb 29, 2012 . Cytomegalovirus (CMV) is one of the most important infections in renal transplant
Apr 30, 2007 . All risk factors were assessed in relation to CMV reactivation, including risk status
Cases (ref), Sex/age/race, Transplant Etiology, CMV status Pre-TX D-R, Evidence
rus (CMV) status is important in a variety of clinical settings such as
CMV status donor/ recipient. Fig. 1. incidence of CMV infection in 73 heart
Impact of donor CMV status on viral infection and reconstitution of multifunction
12 weeks post-transplantation, which responded to specific anti-viral therapy (
Table 1—Clinical Characteristics and CMV Serologic Status of Lung Transplant
It is typically abbreviated as CMV: The species that infects humans is . such as
(2007) Fishman et al. Clinical Transplantation. Read by researchers in: 56%
May 30, 2003 . The study assessed the impact of donor and recipient CMV status on mortality
Jul 1, 1991 . For the last three years we have been collecting data on the CMV status of
Setting: Four university-affiliated transplantation cen- ters. Results: 1-year
recipient CMV serologic status and the frequency ofCMV disease. Table 1.
Donor CMV serologic status and outcome of CMV-seropositive recipients after
The 3 groups were comparable with regard to sex, type of organ transplanted,
Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral
CMV status at time of transplantation and at time of enrolment was determined.
Evaluating Adult Patients Prior to Hematopoietic Cell Transplant . donor factors,
cytomegalovirus status is a detrimental factor for long-term renal allograft survival
Cytomegalovirus in Hematopoietic Stem Cell. Transplant Recipients: Current
Lung Transplant where both patient and donor are CMV negative. Pediatric
Apr 23, 2010 . Current standard practice is to assess CMV status of both donor and recipient
tional CMV-specific CD8 T cells in HCT recipients correlated with the CMV status
status) was also recorded prior to transplant. The following data were collected at
Evaluation of age and CMV status as prognostic factors in match-unrelated donor
Cytomegalovirus antibody status of donor/recipient does not influence the
Cytomegalovirus infection in kidney transplant patients: what is the best way to .
Transplant Unit, Papworth Hospital, Cambridge, UK. heymanluckraz@aol.com.
Sitemap
|